ArticlePolymers2026
Multi-Scale Hydrogen Bonding and Microphase Separation Synergistically Engineered Polyurethane-Polyurea (PU-PUa) as High-Performance Binder.
Article in Polymers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Driven by the rising frequency of extreme climatic events and the escalating demand for sustainable infrastructure, modern pavement materials must deliver enhanced resilience, structural stability, and environmental adaptability. This study presents the design and synthesis of a novel polyurethane-polyurea (PU-PUa) pavement binder, engineered via a synergistic framework combining nanoscale microphase separation and a hierarchical hydrogen-bonding network. Utilizing a streamlined, one-step synthesis approach involving an aliphatic isocyanate, a polyaspartic ester, polytetramethylene ether glycol, and 1,4-butanediol, the PU-PUa copolymer achieves distinct nanoscale phase separation between its hard and soft segments. Fourier transform infrared (FTIR) spectroscopy verifies the successful formation of characteristic PU-PUa moieties and a multi-scale hydrogen-bonding network, while DSC and DMA reveal SSC-dependent soft-segment mobility, crystallization/melting behavior, and viscoelastic relaxation. These intra- and inter-segmental interactions, together with thermally activated soft-segment transitions, establish the structural foundation for the macro-performance enhancement of the system. Comprehensive evaluations demonstrate that the PU-PUa binder exhibits excellent mechanical and highly tunable properties. Rheological measurements indicate that increasing the soft segment content (SSC) or incorporating an appropriate diluent concentration significantly lowers the system viscosity, thereby enhancing processing workability during mixing and paving. Contact angle goniometry reveals that the surface hydrophobicity of PU-PUa can be effectively regulated by adjusting the SSC, offering a viable strategy to optimize moisture damage resistance. Moreover, curing behavior analyses show that the polymerization kinetics are strictly governed by both the SSC and environmental temperature, where a lower SSC or elevated curing temperature accelerates strength development. Mechanically, the PU-PUa binder displays desirable surface hardness (>80 Shore A) and exceptional aggregate adhesion (>2 MPa), ensuring robust bonding stability and resistance to traffic-induced abrasion. Characterized by balanced tensile performance, the elongation at break of the binder can be tailored from 90% to 161%, while its tensile strength varies between 6.4 MPa and 17.8 MPa at intermediate temperatures, manifesting excellent resilience and cracking resistance. Overall, this molecular-to-macroscopic design strategy establishes the PU-PUa copolymer as a highly promising, durable binder for next-generation resilient pavement infrastructures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.